Gene-nutrient interactions with dietary fat modulate the association between genetic variation of the ACSL1 gene and metabolic syndrome

Journal of Lipid Research

Volumn 51, Issue 7, 2010, Pages 1793-1800

  Phillips, Catherine M ^a   Goumidi, Louisa ^b   Bertrais, Sandrine ^b   Field, Martyn R ^c   Adrienne Cupples, L ^d   Ordovas, Jose M ^e   Defoort, Catherine ^b   Lovegrove, Julie A ^f   Drevon, Christian A ^g   Gibney, Michael J ^a   Blaak, Ellen E ^h   Kiec Wilk, Beata ⁱ   Karlstrom, Britta ^j   Lopez Miranda, Jose ^k   McManus, Ross ^l   Hercberg, Serge ^b   Lairon, Denis ^b   Planells, Richard ^b   Roche, Helen M ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b INSERM   (France)

^c Hitachi Dublin Laboratory   (Ireland)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^e TUFTS UNIVERSITY   (United States)

^f UNIVERSITY OF READING   (United Kingdom)

^g UNIVERSITY OF OSLO   (Norway)

^h MAASTRICHT UNIVERSITY   (Netherlands)

ⁱ JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^j UPPSALA UNIVERSITY   (Sweden)

^k HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^l TRINITY COLLEGE DUBLIN   (Ireland)

more..

Author keywords

Fatty acid metabolism; Genetic polymorphisms; Insulin resistance; PUFA

Indexed keywords

GLUCOSE; INSULIN; LONG CHAIN FATTY ACID COENZYME A LIGASE; LONG CHAIN FATTY ACID COENZYME A LIGASE 1; POLYUNSATURATED FATTY ACID; PROTEIN ACSL1; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; FAT INTAKE; FATTY ACID; ISOENZYME; LONG-CHAIN-FATTY-ACID-COA LIGASE;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FAT INTAKE; FATTY ACID METABOLISM; FEMALE; GENE INTERACTION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HETEROZYGOTE; HOMOZYGOSITY; HOMOZYGOTE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NUTRIENT; PRIORITY JOURNAL; RISK ASSESSMENT; FOOD; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HAPLOTYPE; METABOLISM; MIDDLE AGED; NUTRIGENOMICS; PHYSIOLOGY;

ADULT; BIOLOGICAL MARKERS; COENZYME A LIGASES; DIETARY FATS; FATTY ACIDS; FEMALE; FOOD; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HAPLOTYPES; HUMANS; INSULIN RESISTANCE; ISOENZYMES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NUTRIGENOMICS; POLYMORPHISM, GENETIC;

EID: 77953490089     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M003046     Document Type: Article

References (62)

1. Moller, D. E., and K. D. Kaufman. 2005. Metabolic syndrome: a clinical and molecular perspective. Annu. Rev. Med. 56: 45-62.
2. Roche, H. M., C. Phillips, and M. J. Gibney. 2005. The metabolic syndrome: the crossroads of diet and genetics. Proc. Nutr. Soc. 64: 371-377.
3. Unger, R. H. 2002. Lipotoxic diseases. Annu. Rev. Med. 53: 319-336.
4. Ghanim, H., A. Aljada, D. Hofmeyer, T. Syed, P. Mohanty, and P. Dandona. 2004. Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation. 110: 1564-1571.
5. Guilherme, A., J. V. Virbasius, V. Puri, and M. P. Czech. 2008. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Natl. Rev. Mol. Cell. Biol. 9: 367-377.
6. Saltiel, A. R. 2000. Series introduction: the molecular and physiological basis of insulin resistance: emerging implications for metabolic and cardiovascular diseases. J. Clin. Invest. 106: 163-164.
7. Schinner, S., W. A. Scherbaum, S. R. Bornstein, and A. Barthel. 2005. Molecular mechanisms of insulin resistance. Diabet. Med. 22: 674-682.
8. Hall, A. M., A. J. Smith, and D. A. Bernlohr. 2003. Characterization of the Acyl-CoA synthetase activity of purified murine fatty acid transport protein 1. J. Biol. Chem. 278: 43008-43013.
9. McGarry, J. D. 2002. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes. 51: 7-18.
10. Shimabukuro, M., Y. T. Zhou, M. Levi, and R. H. Unger. 1998. Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Proc. Natl. Acad. Sci. USA. 95: 2498-2502.
11. Coleman, R. A., T. M. Lewin, and D. M. Muoio. 2000. Physiological and nutritional regulation of enzymes of triacylglycerol synthesis. Annu. Rev. Nutr. 20: 77-103.
12. Mashek, D. G., L. O. Li, and R. A. Coleman. 2006. Rat long-chain acyl-CoA synthetase mRNA, protein, and activity vary in tissue distribution and in response to diet. J. Lipid Res. 47: 2004-2010.
13. Martin, G., K. Schoonjans, A. M. Lefebvre, B. Staels, and J. Auwerx. 1997. Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARalpha and PPARgamma activators. J. Biol. Chem. 272: 28210-28217.
14. Schoonjans, K., B. Staels, and J. Auwerx. 1996. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J. Lipid Res. 37: 907-925. (Pubitemid 26182326)
15. Kabagambe, E. K., M. Y. Tsai, P. N. Hopkins, J. M. Ordovas, J. M. Peacock, I. B. Borecki, and D. K. Arnett. 2008. Erythrocyte fatty acid composition and the metabolic syndrome: a National Heart, Lung, and Blood Institute GOLDN study. Clin. Chem. 54: 154-162.
16. Phillips, C., J. Lopez-Miranda, F. Perez-Jimenez, R. McManus, and H. M. Roche. 2006. Genetic and nutrient determinants of the metabolic syndrome. Curr. Opin. Cardiol. 21: 185-193.
17. Szabo de Edelenyi, F., L. Goumidi, S. Bertrais, C. Phillips, R. Macmanus, H. Roche, R. Planells, and D. Lairon. 2008. Prediction of the metabolic syndrome status based on dietary and genetic parameters, using Random Forest. Genes Nutr. 3: 173-176.
18. Vessby, B. 2003. Dietary fat, fatty acid composition in plasma and the metabolic syndrome. Curr. Opin. Lipidol. 14: 15-19.
19. Warensjo, E., U. Riserus, and B. Vessby. 2005. Fatty acid composition of serum lipids predicts the development of the metabolic syndrome in men. Diabetologia. 48: 1999-2005.
20. Warensjo, E., J. Sundstrom, L. Lind, and B. Vessby. 2006. Factor analysis of fatty acids in serum lipids as a measure of dietary fat quality in relation to the metabolic syndrome in men. Am. J. Clin. Nutr. 84: 442-448.
21. van Dam, R. M., W. C. Willett, E. B. Rimm, M. J. Stampfer, and F. B. Hu. 2002. Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care. 25: 417-424.
22. Wang, L., A. R. Folsom, Z. J. Zheng, J. S. Pankow, and J. H. Eckfeldt. 2003. Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am. J. Clin. Nutr. 78: 91-98.
23. Meyer, K. A., L. H. Kushi, D. R. Jacobs Jr, and A. R. Folsom. 2001. Dietary fat and incidence of type 2 diabetes in older Iowa women. Diabetes Care. 24: 1528-1535. (Pubitemid 33716444)
24. Storlien, L. H., L. A. Baur, A. D. Kriketos, D. A. Pan, G. J. Cooney, A. B. Jenkins, G. D. Calvert, and L. V. Campbell. 1996. Dietary fats and insulin action. Diabetologia. 39: 621-631.
25. Fasching, P., K. Ratheiser, W. Waldhausl, M. Rohac, W. Osterrode, P. Nowotny, and H. Vierhapper. 1991. Metabolic effects of fishoil supplementation in patients with impaired glucose tolerance. Diabetes. 40: 583-589.
26. Parillo, M., A. A. Rivellese, A. V. Ciardullo, B. Capaldo, A. Giacco, S. Genovese, and G. Riccardi. 1992. A high-monounsaturated-fat/low-carbohydrate diet improves peripheral insulin sensitivity in non-insulin-dependent diabetic patients. Metabolism. 41: 1373-1378.
27. Popp-Snijders, C., J. A. Schouten, R. J. Heine, J. van der Meer, and E. A. van der Veen. 1987. Dietary supplementation of omega-3 polyunsaturated fatty acids improves insulin sensitivity in non-insulin-dependent diabetes. Diabetes Res. 4: 141-147. (Pubitemid 17084024)
28. Vessby, B., M. Unsitupa, K. Hermansen, G. Riccardi, A. A. Rivellese, L. C. Tapsell, C. Nalsen, L. Berglund, A. Louheranta, B. M. Rasmussen, et al. 2001. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study. Diabetologia. 44: 312-319.
29. Blok, W. L., J. P. Deslypere, P. N. Demacker, J. van der Ven-Jongekrijg, M. P. Hectors, J. W. van der Meer, and M. B. Katan. 1997. Pro- and anti-inflammatory cytokines in healthy volunteers fed various doses of fish oil for 1 year. Eur. J. Clin. Invest. 27: 1003-1008.
30. Hartweg, J., R. Perera, V. Montori, S. Dinneen, H. A. Neil, and A. Farmer. 2008. Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Cochrane Database Syst. Rev. CD003205.
31. Lovejoy, J. C., S. R. Smith, C. M. Champagne, M. M. Most, M. Lefevre, J. P. DeLany, Y. M. Denkins, J. C. Rood, J. Veldhuis, and G. A. Bray. 2002. Effects of diets enriched in saturated (palmitic), monounsaturated (oleic), or trans (elaidic) fatty acids on insulin sensitivity and substrate oxidation in healthy adults. Diabetes Care. 25: 1283-1288.
32. Luu, N. T., J. Madden, P. C. Calder, R. F. Grimble, C. P. Shearman, T. Chan, N. Dastur, W. M. Howell, G. E. Rainger, and G. B. Nash. 2007. Dietary supplementation with fish oil modifies the ability of human monocytes to induce an inflammatory response. J. Nutr. 137: 2769-2774.
33. Mayer-Davis, E. J., J. H. Monaco, H. M. Hoen, S. Carmichael, M. Z. Vitolins, M. J. Rewers, S. M. Haffner, M. F. Ayad, R. N. Bergman, and A. J. Karter. 1997. Dietary fat and insulin sensitivity in a tri-ethnic population: the role of obesity. The Insulin Resistance Atherosclerosis Study (IRAS). Am. J. Clin. Nutr. 65: 79-87.
34. Berger, A., D. M. Mutch, J. B. German, and M. A. Roberts. 2002. Dietary effects of arachidonate-rich fungal oil and fish oil on murine hepatic and hippocampal gene expression. Lipids Health Dis. 1: 2.
35. Ringseis, R., and K. Eder. 2005. Effects of dietary fat and oxidized cholesterol on gene expression in rat liver as assessed by cDNA expression array analysis. Eur. J. Nutr. 44: 231-241.
36. Hercberg, S., P. Galan, P. Preziosi, S. Bertrais, L. Mennen, D. Malvy, A. M. Roussel, A. Favier, and S. Briancon. 2004. The SU.VI. MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch. Intern. Med. 164: 2335-2342.
37. Phillips, C. M., L. Goumidi, S. Bertrais, J. F. Ferguson, M. R. Field, E. D. Kelly, G. M. Peloso, L. A. Cupples, J. Shen, J. M. Ordovas, et al. 2009. Complement component 3 polymorphisms interact with polyunsaturated fatty acids to modulate risk of metabolic syndrome. Am. J. Clin. Nutr. 90: 1665-1673.
38. Le Moullec N, D. M., P. Preziosi, P. Monteiro, P. Valeix, M-F. Rolland-Cachera, G. Potier De Courcy, J-P. Christides, F. Cherouvrier, P. Galan, S. Hercberg. 1996. Validation du manuel-photos utilisé pour l'enquête alimentaire de l'étude SU.VI.MAX. Cahiers de Nutrition et de Dietetique. 31: 158-164.
39. Feinberg, M., J. C. Favier, and J. Ireland-Ripert. 1991. Répertoire général des aliments. Fondation Française pour la Nutrition; Centre Informatique sur la Qualité des Aliments. Institut National de la Recherche Agronomique: Technique et Documentation - Lavoisier, France.
40. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). 2001. Jama 285: 2486-2497.
41. Shaw, D. I., A. C. Tierney, S. McCarthy, J. Upritchard, S. Vermunt, H. L. Gulseth, C. A. Drevon, E. E. Blaak, W. H. Saris, B. Karlstrom, et al. 2008. LIPGENE food-exchange model for alteration of dietary fat quantity and quality in free-living participants from eight European countries. Br. J. Nutr. XXX: 1-10.
42. Matthews, D. R., J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner. 1985. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28: 412-419.
43. Perseghin, G., A. Caumo, M. Caloni, G. Testolin, and L. Luzi. 2001. Incorporation of the fasting plasma FFA concentration into QUICKI improves its association with insulin sensitivity in non-obese individuals. J. Clin. Endocrinol. Metab. 86: 4776-4781.
44. Phillips, C. M., L. Goumidi, S. Bertrais, M. R. Field, G. M. Peloso, J. Shen, R. McManus, S. Hercberg, D. Lairon, R. Planells, et al. 2009. Dietary saturated fat modulates the association between STAT3 polymorphisms and abdominal obesity in adults. J. Nutr. 139: 2011-2017.
45. de Bakker, P. I., R. Yelensky, I. Pe'er, S. B. Gabriel, M. J. Daly, and D. Altshuler. 2005. Efficiency and power in genetic association studies. Nat. Genet. 37: 1217-1223.
46. Liang, K. Y., and S. L. Zeger. 1993. Regression analysis for correlated data. Annu. Rev. Public Health. 14: 43-68.
47. Tregouet, D. A., and V. Garelle. 2007. A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies. Bioinformatics. 23: 1038-1039.
48. Saraswathi, V., and A. H. Hasty. 2009. Inhibition of long-chain acyl coenzyme A synthetases during fatty acid loading induces lipotoxicity in macrophages. Arterioscler. Thromb. Vasc. Biol. 29: 1937-1943.
49. International HapMap Consortium. 2003. The International HapMap Project. Nature. 426: 789-796.
50. Picard, F., and J. Auwerx. 2002. PPAR(gamma) and glucose homeostasis. Annu. Rev. Nutr. 22: 167-197.
51. Staels, B., J. Dallongeville, J. Auwerx, K. Schoonjans, E. Leitersdorf, and J. C. Fruchart. 1998. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation. 98: 2088-2093.
52. Staels, B., and J. C. Fruchart. 2005. Therapeutic roles of peroxisome proliferator-activated receptor agonists. Diabetes. 54: 2460-2470. (Pubitemid 41134276)
53. Clemenz, M., N. Frost, M. Schupp, S. Caron, A. Foryst-Ludwig, C. Bohm, M. Hartge, R. Gust, B. Staels, T. Unger, et al. 2008. Liver-specific peroxisome proliferator-activated receptor alpha target gene regulation by the angiotensin type 1 receptor blocker telmisartan. Diabetes. 57: 1405-1413.
54. Forman, B. M., J. Chen, and R. M. Evans. 1997. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc. Natl. Acad. Sci. USA. 94: 4312-4317.
55. Feskens, E. J., J. G. Loeber, and D. Kromhout. 1994. Diet and physical activity as determinants of hyperinsulinemia: the Zutphen Elderly Study. Am. J. Epidemiol. 140: 350-360.
56. Feskens, E. J., C. H. Bowles, and D. Kromhout. 1991. Inverse association between fish intake and risk of glucose intolerance in normoglycemic elderly men and women. Diabetes Care. 14: 935-941.
57. Harris, W. S. 1997. n-3 fatty acids and serum lipoproteins: human studies. Am. J. Clin. Nutr. 65: 1645S-1654S.
58. Li, L. O., J. M. Ellis, H. A. Paich, S. Wang, N. Gong, G. N. Altshuller, R. J. Thresher, T. R. Koves, S. M. Watkins, D. M. Muoio, et al. 2009. Liver-specific loss of long-chain acyl-CoA synthetase-1 decreases triacylglycerol synthesis and beta-oxidation, and alters phospholipid fatty acid composition. J. Biol. Chem. 284: 27816-27826.
59. Neschen, S., K. Morino, L. E. Hammond, D. Zhang, Z. X. Liu, A. J. Romanelli, G. W. Cline, R. L. Pongratz, X. M. Zhang, C. S. Choi, et al. 2005. Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase 1 knockout mice. Cell Metab. 2: 55-65.
60. Lobo, S., B. M. Wiczer, and D. A. Bernlohr. 2009. Functional analysis of long-chain acyl-CoA synthetase 1 in 3T3-L1 adipocytes. J. Biol. Chem. 284: 18347-18356.
61. Mukherjee, R., P. J. Davies, D. L. Crombie, E. D. Bischoff, R. M. Cesario, L. Jow, L. G. Hamann, M. F. Boehm, C. E. Mondon, A. M. Nadzan, et al. 1997. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature. 386: 407-410.
62. Martin, G., H. Poirier, N. Hennuyer, D. Crombie, J. C. Fruchart, R. A. Heyman, P. Besnard, and J. Auwerx. 2000. Induction of the fatty acid transport protein 1 and acyl-CoA synthase genes by dimer-selective rexinoids suggests that the peroxisome proliferator-activated receptor-retinoid X receptor heterodimer is their molecular target. J. Biol. Chem. 275: 12612-12618.